In the largest such study so far undertaken, US researchers have shown that testosterone replacement slows the recurrence of prostate cancer in low-risk ...
Feeds
33553 items (33553 unread) in 74 feeds
Acinar Cell Carcinoma
(229 unread)
Acinic Cell Carcinoma
(128 unread)
Adenoid Cystic Carcinoma
(715 unread)
Adrenal Gland Cancer
(2746 unread)
Ampulla Of Vater
(986 unread)
Anal Cancer
(3470 unread)
Angiosarcoma
(1042 unread)
Appendix Cancer
(455 unread)
Bile Duct Cancer
(3963 unread)
Brain and CNS
(4541 unread)
Carcinoid
(1436 unread)
Endocrine/Neuroendocrine
(3840 unread)
Gall Bladder Cancer
(1495 unread)
Hemangioendothelioma
(345 unread)
Hepatoblastoma
(527 unread)
Pancreas
(433 unread)
Phyllodes
(266 unread)
PMP and Mucinous Tumors
(328 unread)
Rhabdomyosarcoma
(1221 unread)
Sarcoma
(5387 unread)
Google - Acinar Cell Carcinoma (1 unread)
-
Testosterone slows prostate cancer recurrence in low-risk patients - Medical Xpress
Posted: March 17th, 2019, 5:00am GMT
Testosterone slows prostate cancer recurrence in low-risk patients Medical Xpress